We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing Organization

News   Nov 18, 2017

 
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing Organization
 
 
 

RELATED ARTICLES

New Regulators of Macrophage Pyroptosis

News

Two enzymes, TAK1 and IKK, have been identified as important kinases involved in the regulation of pyroptosis - a highly inflammatory form of programmed cell death, which often forms part of the antimicrobial response.

READ MORE

Coffee Compounds Could Team Up to Fight Parkinson’s?

News

Rutgers scientists have found a compound in coffee that may team up with caffeine to fight Parkinson's disease and Lewy body dementia - two progressive and currently incurable diseases associated with brain degeneration.

READ MORE

Statins Have Low Risk of Side Effects

News

The cholesterol-lowering drugs called statins have demonstrated substantial benefits in reducing the risk of heart attacks and strokes caused by blood clots (ischemic strokes) in at-risk patients. Since statins are associated with a low risk of side effects, the benefits of taking them outweigh the risks, according to a scientific statement from the American Heart Association that reviewed multiple studies evaluating the safety and potential side effects of these drugs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE